Subtopic Deep Dive
Ovarian Tissue Cryopreservation
Research Guide
What is Ovarian Tissue Cryopreservation?
Ovarian tissue cryopreservation (OTC) is the process of freezing ovarian cortical tissue prior to gonadotoxic treatments to preserve fertility by enabling future follicle activation and oocyte production.
OTC serves as the primary fertility preservation method for prepubertal girls and patients requiring urgent cancer therapy without time for ovarian stimulation (Lee et al., 2006; 2023 citations). Techniques focus on vitrification to minimize ice crystal damage and improve post-thaw follicle viability. Over 130 live births reported worldwide from OTC-transplantation by 2018 (Oktay et al., 2018; 1418 citations).
Why It Matters
OTC provides fertility options for cancer patients where egg or embryo freezing is not feasible, with ASCO guidelines endorsing it for those facing alkylating chemotherapy (Oktay et al., 2018). ESHRE recommendations highlight OTC's role in transgender men and women delaying childbearing (Anderson et al., 2020; 636 citations). Sönmezer (2004; 496 citations) notes its application in over 650,000 annual U.S. cancer cases affecting young women, restoring endocrine function and enabling 25+ live births via transplantation. Bioprosthetic ovary scaffolds show promise for restoring function in mice (Laronda et al., 2017; 504 citations).
Key Research Challenges
Follicle Viability Post-Thaw
Cryopreservation induces ischemia-reperfusion injury, reducing primordial follicle survival rates below 50% in some protocols (May-Panloup et al., 2016; 528 citations). Optimizing vitrification solutions remains critical for maintaining follicular architecture. No standardized metrics exist for long-term oocyte competence.
Transplantation Outcomes
Orthotopic autotransplantation faces vascular anastomosis challenges, with ischemia limiting graft longevity (Oktay et al., 2018). Live birth rates hover at 20-30% per transplant. Strategies to mitigate follicle loss during revascularization need refinement.
Oncologic Safety
Risk of reseeding malignant cells via contaminated tissue requires rigorous screening (Lambertini et al., 2016; 771 citations). Xenotransplantation models inform safety but lack human validation. Balancing cryopreservation yield with tumor-free assurance persists.
Essential Papers
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
Stephanie J. Lee, Leslie R. Schover, Ann H. Partridge et al. · 2006 · Journal of Clinical Oncology · 2.0K citations
Purpose To develop guidance to practicing oncologists about available fertility preservation methods and related issues in people treated for cancer. Methods An expert panel and a writing committee...
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update
Kutluk Oktay, Brittany Harvey, Ann H. Partridge et al. · 2018 · Journal of Clinical Oncology · 1.4K citations
Purpose To provide current recommendations about fertility preservation for adults and children with cancer. Methods A systematic review of the literature published from January 2013 to March 2017 ...
Cancer and fertility preservation: international recommendations from an expert meeting
Matteo Lambertini, Lucia Del Mastro, M. Pescio et al. · 2016 · BMC Medicine · 771 citations
ESHRE guideline: female fertility preservation†
Richard A. Anderson, Frédéric Amant, D.D.M. Braat et al. · 2020 · Human Reproduction Open · 636 citations
Abstract STUDY QUESTION What is the recommended management for women and transgender men with regards to fertility preservation (FP), based on the best available evidence in the literature? SUMMARY...
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Nick Macklon, Richard L. Stouffer, Linda C. Giudice et al. · 2006 · Endocrine Reviews · 569 citations
To allow selection of embryos for transfer after in vitro fertilization, ovarian stimulation is usually carried out with exogenous gonadotropins. To compensate for changes induced by stimulation, G...
<i>C. elegans</i> dauer formation and the molecular basis of plasticity
Nicole Fielenbach, Adam Antebi · 2008 · Genes & Development · 565 citations
Because life is often unpredictable, dynamic, and complex, all animals have evolved remarkable abilities to cope with changes in their external environment and internal physiology. This regulatory ...
Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE
A. Nyboe Andersen, V. Goossens, Anna Pia Ferraretti et al. · 2008 · Human Reproduction · 563 citations
Compared with earlier years, the reported number of ART cycles in Europe increased and the pregnancy rates increased marginally, even though fewer embryos were transferred and the multiple delivery...
Reading Guide
Foundational Papers
Start with Lee et al. (2006; 2023 citations) for ASCO's initial OTC endorsement in cancer patients; Sönmezer (2004; 496 citations) for early female preservation strategies; Macklon et al. (2006; 569 citations) contextualizes ovarian stimulation limits driving OTC need.
Recent Advances
Oktay et al. (2018; 1418 citations) updates live birth data; Anderson et al. (2020; 636 citations) provides ESHRE protocols; Laronda et al. (2017; 504 citations) advances 3D-printed ovary scaffolds.
Core Methods
Vitrification protocols (Oktay et al., 2018); mitochondrial assessment in ageing follicles (May-Panloup et al., 2016); orthotopic transplantation techniques (Anderson et al., 2020).
How PapersFlow Helps You Research Ovarian Tissue Cryopreservation
Discover & Search
Research Agent uses searchPapers and citationGraph on 'ovarian tissue cryopreservation live births' to map 200+ papers from Lee et al. (2006) hubs, revealing ASCO guideline evolution; exaSearch uncovers 50 niche vitrification protocols; findSimilarPapers expands from Laronda et al. (2017) to 3D scaffold analogs.
Analyze & Verify
Analysis Agent applies readPaperContent to parse Oktay et al. (2018) for live birth rates, then verifyResponse with CoVe chain-of-verification cross-checks claims against Anderson et al. (2020); runPythonAnalysis statistically compares follicle survival data from May-Panloup et al. (2016) via pandas survival curves; GRADE grading scores ESHRE evidence as high for OTC efficacy.
Synthesize & Write
Synthesis Agent detects gaps in transplantation ischemia mitigation across Lambertini et al. (2016) and Sönmezer (2004); Writing Agent uses latexEditText for protocol comparisons, latexSyncCitations integrates 20 references, latexCompile generates review PDFs; exportMermaid visualizes OTC workflow from cryopreservation to live birth.
Use Cases
"Analyze post-thaw follicle survival rates from OTC papers with statistics."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis of viability data from May-Panloup et al., 2016) → matplotlib survival plots output.
"Write LaTeX review on OTC guidelines comparing ASCO and ESHRE."
Research Agent → citationGraph → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Oktay 2018, Anderson 2020) → latexCompile → formatted PDF.
"Find code for OTC vitrification modeling from papers."
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for cryopreservation simulations output.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ OTC papers via searchPapers → citationGraph → GRADE grading, outputting structured report on live birth trends from Lee (2006) to Laronda (2017). DeepScan applies 7-step analysis with CoVe checkpoints to verify transplantation safety claims in Lambertini et al. (2016). Theorizer generates hypotheses on mitochondrial protection in OTC from May-Panloup et al. (2016).
Frequently Asked Questions
What is ovarian tissue cryopreservation?
OTC freezes ovarian cortex strips containing primordial follicles before gonadotoxic therapy, allowing post-treatment orthotopic transplantation to restore fertility (Oktay et al., 2018).
What are key methods in OTC?
Vitrification with dimethyl sulfoxide and ethylene glycol minimizes ice formation; slow-freezing alternatives used pre-2010; post-thaw xenografts assess viability (Anderson et al., 2020).
What are landmark papers on OTC?
ASCO guidelines by Lee et al. (2006; 2023 citations) first endorsed OTC; Oktay et al. (2018; 1418 citations) updated with 130+ live births; ESHRE by Anderson et al. (2020; 636 citations) standardized protocols.
What open problems remain in OTC?
Improving long-term graft survival beyond 1-2 years, eliminating malignancy risk, and scaling bioprosthetic scaffolds to humans (Laronda et al., 2017; Lambertini et al., 2016).
Research Reproductive Biology and Fertility with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Ovarian Tissue Cryopreservation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers